| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...870164V |
| P356 | DOI | 10.1371/JOURNAL.PONE.0070164 |
| P932 | PMC publication ID | 3729685 |
| P698 | PubMed publication ID | 23936155 |
| P5875 | ResearchGate publication ID | 259758831 |
| P50 | author | Jintanat Ananworanich | Q75156178 |
| Victor G Valcour | Q90051563 | ||
| Bonnie Slike | Q104129904 | ||
| Cecilia M Shikuma | Q114270873 | ||
| Mary A Marovich | Q114291777 | ||
| P2093 | author name string | Robert Paul | |
| David B Clifford | |||
| Napapon Sailasuta | |||
| Pasiri Sithinamsuwan | |||
| Bruce Shiramizu | |||
| Melissa Agsalda | |||
| James L K Fletcher | |||
| Somporn Tipsuk | |||
| Thep Chalermchai | |||
| Alexandra Schuetz | |||
| Chin-Yuan Liang | |||
| Supunee Jirajariyavej | |||
| Victor DeGruttola | |||
| SEARCH 011 Protocol Team | |||
| P2860 | cites work | Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection. | Q51906942 |
| Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. | Q54057499 | ||
| Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. | Q54660101 | ||
| HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is | Q61240446 | ||
| Estimation of metabolite concentrations from localized in vivo proton NMR spectra | Q72319396 | ||
| On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain | Q73431776 | ||
| The neuropathogenesis of AIDS | Q28300983 | ||
| Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy | Q29615993 | ||
| Theory and application of array coils in MR spectroscopy | Q32067997 | ||
| HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications | Q33805298 | ||
| Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage | Q33864438 | ||
| Circulating proviral HIV DNA and HIV-associated dementia | Q35012478 | ||
| Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. | Q35186413 | ||
| Updated research nosology for HIV-associated neurocognitive disorders | Q35755761 | ||
| Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders | Q36670527 | ||
| HIV proviral DNA associated with decreased neuropsychological function | Q36683785 | ||
| Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders | Q36929643 | ||
| Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV. | Q37024994 | ||
| HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study | Q37180359 | ||
| Cellular reservoirs of HIV-1 and their role in viral persistence | Q37196089 | ||
| HIV interactions with monocytes and dendritic cells: viral latency and reservoirs | Q37229398 | ||
| Influence of HAART on HIV-related CNS disease and neuroinflammation. | Q40411104 | ||
| Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy | Q42130105 | ||
| Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia | Q42474669 | ||
| Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection | Q43716030 | ||
| WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings | Q46416559 | ||
| Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand. | Q48076295 | ||
| HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement | Q48343313 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e70164 | |
| P577 | publication date | 2013-07-31 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients | |
| P478 | volume | 8 |
| Q36250205 | Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection |
| Q35220349 | Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand |
| Q38948215 | Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders |
| Q41716577 | Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control |
| Q54218501 | Characterization of Cellular Immune Responses in Thai Individuals with and without HIV-Associated Neurocognitive Disorders. |
| Q36316590 | Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART |
| Q46531545 | Clinical Relevance of Total HIV DNA in Peripheral Blood Mononuclear Cell Compartments as a Biomarker of HIV-Associated Neurocognitive Disorders (HAND). |
| Q30250271 | Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls |
| Q47558623 | Cognition, emotional health, and immunological markers in children with long-term nonprogressive HIV. |
| Q35797131 | Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR |
| Q89620873 | Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs |
| Q36238501 | Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations |
| Q55255033 | EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. |
| Q93383858 | Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals |
| Q26865141 | Exosomes as mediators of neuroinflammation |
| Q38654347 | Frontline Science: CXCR7 mediates CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. |
| Q34221268 | HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy |
| Q88660087 | HIV-associated neurocognitive disorder |
| Q38433342 | High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection |
| Q64129975 | High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children |
| Q35880399 | Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women's Interagency HIV Study (WIHS). |
| Q88753335 | Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism |
| Q58775726 | In Vitro Blood-Brain Barrier Modeling adapted for Peripheral Blood Mononuclear Cell Transmigration from HIV-Positive Patients for Clinical Research on Therapeutic Drug Intervention |
| Q90616753 | Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy |
| Q36250020 | Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais |
| Q92072174 | Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection |
| Q40478716 | Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression. |
| Q35154529 | Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders |
| Q35837184 | Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV |
| Q35149362 | Neurology and the Global HIV Epidemic |
| Q36463660 | Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy |
| Q35057044 | Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism |
| Q59359821 | Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities |
| Q40315607 | Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria |
| Q35325801 | Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition |
| Q40507828 | Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection |
| Q38247035 | Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system |
| Q94475288 | Phyloanatomic characterization of the distinct T cell and monocyte contributions to the peripheral blood HIV population within the host |
| Q91947425 | Post-traumatic Stress Disorder, Cocaine Use, and HIV Persistence |
| Q35652578 | Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment |
| Q36957941 | Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals |
| Q28066725 | The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review |
| Q91811483 | The HIV Reservoir in Monocytes and Macrophages |
| Q35814748 | The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy |
| Q35883236 | The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India |
| Q34718135 | Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-a |
| Q42203691 | Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics |
| Q35264787 | Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection |
Search more.